NCT00510159View on ClinicalTrials.gov

Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

December 31, 2007

Conditions
Schistosoma Haematobium
Interventions
DRUG

Artesunate+Sulfamethoxypyrazine/pyrimethamin

DRUG

Praziquantel

Trial Locations (1)

Unknown

Djalakorodji

Sponsors

Lead Sponsor

Dafra Pharma
All Listed Sponsors
lead

Dafra Pharma

INDUSTRY

NCT00510159 - Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis | Biotech Hunter | Biotech Hunter